Table 2.
Echocardiography and MRI data of participants according to the MetSyn status
| Variable | Without MetSyn (n = 92) Mean ± SD | With MetSyn (n = 41) Mean ± SD | p value |
|---|---|---|---|
| εCC (%) [STE] | -18.4 ± 3.7 | -16.3 ± 3.5 | < 0.01 |
| εCC (%) [MRI] | -17.6 ± 2.3 | -15.8 ± 3.3 | < 0.01 |
| εLL (%) [STE] | -13.9 ± 2.3 | -12.1 ± 2.5 | < 0.01 |
| LVEF (%) [MRI] | 61 ± 5 | 59 ± 4 | 0.09 |
| LV mass (g) [MRI] | 120 ± 28 | 136 ± 35 | < 0.01 |
| LV mass index (g/m2) [MRI] | 65 ± 11 | 68 ± 13 | 0.18 |
| LVID (mm) [Echo] | 46 ± 6 | 44 ± 5 | 0.15 |
εCC:circumferential strain; εLL: longitudinal strain; LV: left ventricle; LVEF: LV ejection fraction; LVID: LV internal diameter; MetSyn: Metabolic Syndrome; MRI: magnetic resonance imaging; STE: speckle tracking echocardiography.